![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA ANNOUNCES CLASSIFICATION OF INFUSION DEVICE RECALL AS CLASS I
FDA ANNOUNCES CLASSIFICATION OF INFUSION DEVICE RECALL AS CLASS I
The FDA July 21 announced it has classified a recent recall of Disetronic's Accu-Chek Ultraflex-1 infusion set as Class I.
The manufacturer, Indianapolis-based Roche, initiated a recall March 31 for the device, an insulin pump that delivers continuous short-acting or fast-acting U100 insulin to treat diabetes mellitus.
The Class I recall has been issued because the "tubing may fully or partially separate at the luer lock-tubing connection," causing insulin to leak, the FDA said. Such a separation can interrupt insulin delivery and lead to hyperglycemia, the agency added.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct